Citadel Advisors’s Vapotherm, Inc. Common Stock VAPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,032
Closed -$22.3K 15840
2022
Q4
$22.3K Buy
+1,032
New +$11.7K ﹤0.01% 13055
2022
Q3
Sell
-6,029
Closed -$122K 13924
2022
Q2
$122K Buy
6,029
+2,885
+92% +$106K ﹤0.01% 11195
2022
Q1
$350K Sell
3,144
-13,632
-81% -$1.7M ﹤0.01% 10237
2021
Q4
$2.78M Buy
16,776
+2,919
+21% +$505K ﹤0.01% 5483
2021
Q3
$2.47M Sell
13,857
-11,829
-46% -$2.4M ﹤0.01% 5837
2021
Q2
$4.86M Buy
25,686
+14,185
+123% +$2.42M ﹤0.01% 4506
2021
Q1
$2.21M Sell
11,501
-2,419
-17% -$561K ﹤0.01% 6156
2020
Q4
$2.99M Buy
13,920
+9,293
+201% +$2.07M ﹤0.01% 4586
2020
Q3
$1.07M Sell
4,627
-14,842
-76% -$4.28M ﹤0.01% 5912
2020
Q2
$6.38M Buy
19,469
+17,476
+877% +$3.68M ﹤0.01% 2748
2020
Q1
$300K Buy
+1,993
New +$180K ﹤0.01% 7344

Other funds holding VAPO

Citadel Advisors's VAPO Position: Q1 2023 in Review

Citadel Advisors sold out of Vapotherm, Inc. Common Stock (VAPO) in Q1 2023, closing a stake of 1,032 shares — an estimated $22.3K sold.

Citadel Advisors first reported a position in VAPO in Q1 2020 and held it in 11 quarters. The position peaked at $6.38M in Q2 2020. 51 funds tracked by Wall St. Rank hold VAPO as of Q1 2023.

  • Citadel Advisors reported no remaining Vapotherm, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 1,032 Vapotherm, Inc. Common Stock shares in Q1 2023, an estimated $22.3K.
  • Citadel Advisors first reported a position in Vapotherm, Inc. Common Stock in Q1 2020 and held it in 11 quarters.
  • Citadel Advisors's Vapotherm, Inc. Common Stock position peaked at $6.38M in Q2 2020.
  • 51 funds tracked by Wall St. Rank held Vapotherm, Inc. Common Stock as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.